Main content Main content

3D Bioprinter

Innovating healthcare, producing human tissues by 3D positioning of cells


With the discovery of iPS cells (induced pluripotent stem cells), which differentiate into many different types of cells, eyes of the world are on regenerative medicine—restoring physical functions lost due to disease and injury.
The technology to build three-dimensional biological tissue from iPS cells also goes beyond regenerative medicine. Research and development efforts are being accelerated, at the prospects for its application to finding causes of diseases, developing new pharmaceuticals, and testing the safety and toxicity of drugs and cosmetics.


To reproduce biological tissue structures that are close to those of living bodies, you need to appropriately arrange different types of cells and assemble them three-dimensionally.
Research and development of 3D bioprinters is under way at Ricoh. This technology uses an original inkjet system, which can arrange cells very precisely. It will lead to the production of artificial human tissues that are very close to those of living bodies.

Solutions image

Technical highlights

Ricoh has been putting effort into the development of new inkjet head and bioink for printing of living cells.
These technologies enabled Ricoh to create inkjet-based bioprinting, which can precisely deposit living cells in layer-by-layer fashion.

Ricoh's vision

The vision of Ricoh is to be innovation leader in healthcare by providing functional tissues and organs using our bioprinting for organ replacement and drug discovery.

*This research was partially supported by Japan Agency for Medical Research and Development (AMED)

qq刮刮乐zi 支付宝运动赛能赚多少 两分彩全天计划网址 快乐赛车5分钟开奖 快乐十分黑龙江 qq麻将手机版官方下载 新疆时时彩开奖结果时彩走势图 上海明星麻将 三国麻将小游戏下载 欧冠视频巴黎 斗牛棋牌挣钱app 南京麻将app 重庆快乐10分一定牛 科乐吉林麻将安卓手机 浙江6+1开奖查询 捕鱼电玩城官方下载 大地棋牌官方推荐下载站